Literature DB >> 17676382

An abdominal pain syndrome in a lupus patient.

T Cornelis1, C Breynaert, D Blockmans.   

Abstract

Systemic lupus erythematosus can be complicated by the antiphospholipid syndrome (APS). The clinical manifestations of this syndrome most often documented thus far are recurrent deep venous thrombosis, recurrent spontaneous abortions, and cerebral vascular accidents. Abdominal ischemic events have received relatively little attention in prior reports. We report on a lupus patient with lupus anticoagulant positivity who presented with abdominal pain, anorexia, and weight loss who was subsequently diagnosed with gastric ulcers and pancreatitis. Computerized tomography of the abdomen in addition revealed splenic and kidney infarcts. We conclude that this patient had (ischemic) chronic pancreatitis with pseudocysts and splenic and renal infarcts probably due to secondary APS.

Entities:  

Mesh:

Year:  2007        PMID: 17676382     DOI: 10.1007/s10067-007-0711-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis.

Authors:  M Stegnar; B Bozic; P Peternel; T Kveder; N Vene; B Rozman
Journal:  Thromb Res       Date:  1991-08-15       Impact factor: 3.944

Review 2.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

3.  Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.

Authors:  M Samarkos; K A Davies; C Gordon; S Loizou
Journal:  Clin Rheumatol       Date:  2005-08-10       Impact factor: 2.980

Review 4.  Lupus-associated pancreatitis.

Authors:  Gabriel S Breuer; Asher Baer; David Dahan; Gideon Nesher
Journal:  Autoimmun Rev       Date:  2006-01-27       Impact factor: 9.754

5.  The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors:  R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

6.  Assessment of the 2006 revised antiphospholipid syndrome classification criteria.

Authors:  Mala Kaul; Doruk Erkan; Lisa Sammaritano; Michael D Lockshin
Journal:  Ann Rheum Dis       Date:  2007-03-02       Impact factor: 19.103

7.  Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  Mary J Roman; Beth-Ann Shanker; Adrienne Davis; Michael D Lockshin; Lisa Sammaritano; Ronit Simantov; Mary K Crow; Joseph E Schwartz; Stephen A Paget; Richard B Devereux; Jane E Salmon
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

8.  Pancreatitis related to antiphospholipid antibody syndrome in a patient with systemic lupus erythematosus.

Authors:  C R Wang; H C Hsieh; G L Lee; C Y Chuang; C Y Chen
Journal:  J Rheumatol       Date:  1992-07       Impact factor: 4.666

  8 in total
  1 in total

Review 1.  Life-threatening spontaneous splenic rupture with systemic lupus erythematosus: case report and literature review.

Authors:  Jie Han; Ning Li; JiaYi Wang; JieRu Zhou; Jie Zhang
Journal:  Clin Rheumatol       Date:  2012-02-11       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.